Efficacy of eculizumab against Eosinophilic Fasciitis associated with Paroxysmal Nocturnal Haemoglobinuria

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e101-e102. doi: 10.1111/jdv.13819. Epub 2016 Jul 12.

Authors

L Frumholtz¹, M Sebert^{2

3}, A de Masson¹, P Attias³, L Ades^{2

3}, J Roux^{1

2}, M Jachiet¹, A Cabannes-Hamy⁴, M Elena Noguera⁵, C Attencourt⁶, M Bagot^{1

2}, G Socié^{2

4}, M Rybojad^{1

2}, R Peffault de La Tour^{2

4}, J D Bouaziz^{1

2}

Affiliations

¹ Dermatology Department, Saint-Louis Hospital, Paris, France.
² Paris VII Sorbonne Paris Cité University, Paris, France.
³ Hematology Department, Saint-Louis Hospital, Paris, France.
⁴ Hematology and Transplantation, Saint-Louis Hospital, Paris, France.
⁵ Laboratory of Hematology, Saint-Louis Hospital, Paris, France.
⁶ Pathology Department, CHU Amiens, Amiens, France.

PMID: 27401544
DOI: 10.1111/jdv.13819

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Eosinophilia / complications
Eosinophilia / drug therapy*
Fasciitis / complications
Fasciitis / drug therapy*
Hemoglobinuria, Paroxysmal / complications
Hemoglobinuria, Paroxysmal / drug therapy*
Humans
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
eculizumab

Supplementary concepts

Eosinophilic Fasciitis